Publications - Fortunato Bianconi

Filter:
 

Year: 2012

  • S. Ciotti, F. Scarponi, F. Bianconi, B. Maddalena, B. Alessandra and Z. Mauro. "Icf role in the definition of als rehabilitation project". 2012. [More]
  • F. Stracci et al.. "Influence of screening on colorectal cancer incidence , survival, and stage at diagnosis: differences by gender". 2012. [More]
  • F. Bianconi et al.. "SYSTEMS BIOLOGY IN TRANSLATIONAL ONCOLOGY: COMPUTATIONAL AND EXPERIMENTAL STUDY OF EGFR AND IGF1R PATHWAYS IN NSCLC CELL LINES". Annals of Oncology. 2012. [More]
  • L. Vienna, A. Flacco, F. Bianconi and M. Varella-Garcia. "Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease free survival of surgically resected non-small-cell-lung cancer patients", Cancer Chemotherapy and Pharmacology. 2012. [More]
  • F. Bianconi et al.. "Systems biology in personalized medicine in oncology: A case study in non-small cell lung cancer.". J Clin Oncol 30, 2012 (suppl; abstr e21096). 2012. [More]
  • V. Ludovini et al.. "PROGNOSTIC ROLE OF ERBB FAMILY RECEPTORS, MYC AND MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) IN PATIENTS WITH EARLY-STAGE NON SMALL-CELL LUNG CANCER". 37th ESMO Congress Vienna, Austria, 28 September – 2 October 2012. 2012. [More]
  • M. Ragusa et al. "Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non-small cell lung cancer patients.", American Journal of Clinical Oncology. 2012. [More]

Year: 2011

  • V. Ludovini et al. "Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET and non-sensitizing EGFR mutations", Cancer Chemotherapy and Pharmacology. 2011. [More]
  • F. Bianconi, V. Brunori, P. Valigi, F. La Rosa and F. Stracci. "Information technology as tools for Cancer Registry and Regional Cancer Network integration.", IEEE TRANSACTIONS ON SYSTEMS MAN AND CYBERNETICS PART A-SYSTEMS AND HUMANS. 2011. [More] [Full text]
  • A. Siggillino et al.. "Gene expression profiling of lung adenocarcinoma stage I patients and risk for relapse disease.". ECCO 2011, September, Stockholm. 2011. [More]
  • F. Bianconi, E. Baldelli, V. Ludovini, L. Crinò, A. Flacco and P. Valigi. "Computational model of EGFR and IGF1R pathways in lung cancer: a Systems Biology approach for Translational Oncology", Biotechnology Advances, Vol. Accepted. 2011. [More]
  • L. Vienna, A. Flacco, F. Bianconi, M. Varella-Garcia and L. Crinò. "Insulin-like growth factor receptor 1 (IGF1R) and epidermal growth factor receptor (EGFR) amplification and expression in surgically resected NSCLC". J Clin Oncol 29: 2011 (suppl; abstr 10519) American Society of Clinical Oncology - ASCO. 2011. [More]
  • A. Flacco, V. Ludovini, F. Bianconi, G. Bellezza, M. Varella-Garcia and L. Crinò. "MYC and human telomerase gene (TERC) gene copy number gain in resected in non-small cell lung cancer (NSCLC)". J Clin Oncol 29: 2011 (suppl; abstr 10580) American Society of Clinical Oncology - ASCO. 2011. [More]
  • V. Ludovini et al.. "Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients". 14th World Conference on Lung Cancer. 2011. [More]
  • F. Bianconi, L. Gabriele and P. Valigi. "Dynamic modeling and parameter identification for biological networks: application to the DNA damage and repair processes". L. L. A., W. D. and L. Y. EDS eds. Shanghai : Limin Angela Liu, Dongqing Wei, and Yixue Li Eds. 2011. [More] [Online version]
  • V. Ludovini et al. "PIK3CA and KRAS mutations are important predictors of resistance to therapy with EGFR-tyrosine kinase inhibitors in advanced non small cell lung cancer patients.", JOURNAL OF THORACIC ONCOLOGY. 2011. [More] [Online version]

Year: 2010

  • F. Stracci, F. Bianconi, M. Scheibel, M. D. Giaimo and F. La Rosa. "Staging, missing prognostic information and colorectal cancer control in Umbria". XXXV GRELL MEETING. 2010. [More]
  • F. Bianconi, V. Brunori, P. Valigi, F. Stracci and F. La Rosa. "Cancer Registry and information technology: a new management system for integrating Cancer Registry and Oncology Departments". 2010. [More]
  • F. Bianconi. "Dynamic modeling, parameter estimation and experiment design in Systems Biology with applications to Oncology.". Perugia. 2010. [More]
  • V. Ludovini et al.. "Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of MET, EGFR, KRAS, and PIK3CA mutations". J. Clin Oncol ed. 2010. pp. 7562. [More]
  • F. Bianconi, M. Boccadoro, V. Ludovini and P. Valigi. "Systems Biology and translational oncology: a case study of predictive modeling in molecular biology of the lung cancer.". 2010. [More]
  • F. Stracci, F. Bianconi, F. La Rosa and M. Tonato. "Cancer registry integration in the Umbria Regional Cancer Network: breast cancer as a model to build a supportive information system.". 2010. [More]
  • V. Ludovini, F. Bianconi and L. Crinò. "Prognostic and predictive role of PIK3CA mutations in non small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors". 2010. [More]

Year: 2009

  • V. Ludovini et al. "High coexpression of both insulin-like growth factor receptor 1 (igfr-1) and epidermal growth factor receptor (egfr) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients", Annals Oncology, Vol. 5. 2009, pp. 842-849. [More]
  • R. Petraroli et al.. "KRAS gene mutation testing an inter-laboratory validated workflow for quality assured, clinical-grade results using capillary electrophoresis". J. of Human Genetics ed. 2009. [More]
  • F. Bianconi, M. Boccadoro, G. Lillacci and P. Valigi. "A strategy for parameter estimation for mRNA and protein dynamics". International Conference on Computational and Systems Biology (ICCSB). 2009. [More]

Year: 2008

  • L. Crinò et al.. "EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients". J. of Clinical Oncology ed. 2008. [More]
  • F. Bianconi and H. El Samad. "A New Strategy for Parameter Estimation in Computational Models of Cellular Networks". 2008. [More]
  • F. Bianconi and H. El Samad. "Envelope stress response in E.Coli: computational model". E. principles in Biological systems ed. 2008. [More]

Year: 2007

  • F. Bianconi, G. Lillacci and P. Valigi. "A hybrid model of nucleotide excision repair in neoplastic diseases: the identification problem". 2007. [More]

Year: 2006

  • F. Bianconi et al.. "A Hybrid Model of Nucleotide Excision Repair in Neoplastic diseases and in vitro Experiments". Dipartimento di Ingegneria Elettronica e dell’Informazione. 2006. [More]
Results 1 - 31 of 31